| AUTORES | Paquet M, Cerasuolo JO, Thorburn V, Fridman S, Alsubaie R, Lopes RD, Cipriano LE, Salamone P, Melling CWJ, Khan AR, Sedeño L, Fang J, Drangova M, Montero-Odasso M, Mandzia J, Khaw AV, Racosta JM, Paturel J, Samoilov L, Stirling D, Balint B, Jaremek V, Koschinsky ML, Boffa MB, Summers K, Ibañez A, Mrkobrada M, Saposnik G, Kimpinski K, Whitehead SN, Sposato LA. |
|---|---|
| AÑO | 2017 |
| JOURNAL | Journal of Stroke Cerebrovascular Diseases |
| VOLUMEN | November 13, 2017 |
| ABSTRACT | It has been hypothesized that ischemic stroke can cause atrial fibrillation. By elucidating the mechanisms of neurogenically mediated paroxysmal atrial fibrillation, novel therapeutic strategies could be developed to prevent atrial fibrillation occurrence and perpetuation after stroke. This could result in fewer recurrent strokes and deaths, a reduction or delay in dementia onset, and in the lessening of the functional, structural, and metabolic consequences of atrial fibrillation on the heart. |
| RESUMEN | El accidente cerebrovascular isquémico podría causar fibrilación auricular cardiaca. Presentamos la iniciativa traslacional denominada Pathophysiology and Risk of Atrial Fibrillation Detected after Ischemic Stroke (PARADISE). Comprende 3 líneas de investigación: experimental (electrocardiográfica, autonómica, anatómica, animales), clínica (cambios autonómicos, inflamatorios y neurocognitivos en fibrilación auricular post-stroke) y epidemiológica (Ontario Stroke Registry de 23000 pacientes). PARADISE podría ayudar a reducir accidentes cerebrovasculares, muertes recurrentes, inicio temprano de la demencia, y consecuencias de la fibrilación auricular en el corazón. |